Return to Bioenergetic Support Page

Ribose in CHF

Regardless of the underlying cause, the condition of heart failure is associated with dilation of the left ventricle and an increased intraventricular filling pressure (because the heart is stiff, the blood pressure within the heart will rise).  These two forces strain the heart, such that it needs to generate more ATP energy.  Even if its oxygen supply is normal, the heart often cannot make enough ATP to meets this increased demand; its cellular ATP content will be burned off in to ADP, AMP, and finally to adenosine, which leaves the cell to be lost forever.  The heart is in worse shape now, without the building blocks from which to regenerate ATP, so it's functional status deteriorates further.  If ribose is supplied as a supplement, the failing heart should be able to get back in to ATP production mode, such that its performance could improve.  This makes sense in theory - let's see if ribose will work in patients with CHF:

Fifteen patients with NYHA Functional Class II-III heart failure (symptoms with mild to moderate effort) on the basis of coronary disease with prior heart attack, were evaluated before and after three weeks of treatment with placebo or with ribose at a  dose of 5 gm. three times a day.  The subjects were then crossed over to the opposite treatment regimen following a one week wash out period.  A double blind protocol was followed.

            E Wave Deceleration Time                           Left Atrial Volume                                                                                                                 
 E wave deceleration time, an echo marker of diastolic function, improved.  In other words the heart was less stiff.  The anatomic correlate was a decrease in the size of the left atrium.  If the left ventricle fills better and is less stiff, then the blood pressure within the heart will fall, the back pressure into the left atrium and the lungs will fall, and the left atrium will decrease in size.  If the back pressure in to the lungs falls, we would expect that you would be able to do more, and that the quality of your life would improve.

 

 

 

 

               Quality of Life Score                          Physical Functioning Score

Neither quality of life or physical functioning improved significantly with placebo therapy.  With ribose supplementation, however, the subjects experienced a significant improvement in functional status and overall quality of life.  In other words, they could do more, and their lives were more enjoyable.  Ribose did not produce any side-effects, a typical characteristic of nutritional therapies.

 

If you have heart failure, supplementation with ribose makes perfect sense.  The starting dose is 5 gm. three times a day.  The only potential down side of ribose is a mild drop in blood sugar in diabetic patients receiving insulin, an issue that is easy to address.

                                                                                                                                                                James C. Roberts MD FACC
                                                                                                                                                                                                  1/01/07